TAP Archives - Ingredientpharm

CPhI 2024: Welcome ingredientpharm in Milan/Italy

We are thrilled to announce ingredientpharm’s participation as an exhibitor at the prestigious CPhI worldwide exhibition, taking place on October 08-10, 2024, in Milan/Italy, booth 7B66. As a leading name in the pharmaceutical ingredients industry, ingredientpharm is dedicated to advancing the quality and efficacy of pharmaceutical excipients and API granulation. This year, we are excited to showcase our latest innovations and high-quality offerings: pharmaceutical pellets and granulated Ibuprofen DC100.

Pharmaceutical Pellets: Made for better formulations

At ingredientpharm, we understand the critical importance of precision and consistency in pharmaceutical manufacturing. Our pharmaceutical pellets are meticulously engineered to meet the highest standards of quality, uniformity and applicability to state-of-the-art formulations. These pellets offer superior opportunities for modified release profiles, enhancing the effectiveness of medications and ensuring patient compliance. Our advanced pelletization technologies guarantees that every batch delivers consistent quality, performance, providing pharmaceutical manufacturers with the reliability they need to produce safe and effective medicines. You have the choice for inert MCC pellets (CELLETS®) or functional starter beads (TAP®).

Granulated Ibuprofen DC100: A revolution in pain management

Introducing our groundbreaking product, granulated Ibuprofen DC100, a direct compression grade of Ibuprofen designed to streamline the tablet manufacturing process. This innovative granulation eliminates the need for complex processing steps, significantly reducing production time and costs. Ibuprofen DC100 is made of 100% API and comes without any need of further excipients. Ibuprofen DC100 ensures excellent flowability, compressibility, and dissolution properties, making it an ideal choice for manufacturers seeking to optimize their formulations. With this product, ingredientpharm is setting new standards in the production of non-steroidal anti-inflammatory drugs (NSAIDs), providing a reliable solution for effective pain management.

Visit Us at CPhI 2024

We invite you to visit our booth at CPhI 2024 to learn more about our cutting-edge pharmaceutical pellets and granulated Ibuprofen DC100. Our experts will be on hand to discuss how these products can enhance your formulation, improve efficiency, and benefit patients. Join us in exploring the future of pharmaceutical ingredients and discover why ingredientpharm is a trusted partner in the industry.

We look forward to seeing you at CPhI 2024 in Italy!

Glatt

Online seminar recording: Functional Tartaric Acid Pellets in Modern Formulation Challenges

Apr 05, 2022. Register for the online seminar recordings: “Functional Tartaric Acid Pellets in Modern Formulation Challenges”.
Speakers: Philippe Tschopp, Raja Subburayalu, with kind session chair by Marco Resciniti.
Sponsoring companies: Glatt Group, ingredientpharm, PHARMATRANS SANAQ AG, HARKE GROUP.
Target group: for Manager working in Pharmaceutical Technology and Formulation Sciences.

Register here: Webinar-Registrierung – Zoom

Abstract: Functional Tartaric Acid Pellets in Modern Formulation Challenges

Multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption. Present generic formulations focus on these so-called BSC Class IV drugs. The Role of Reverse Engineering is thereby an efficient key tool in the development of generic formulations. A Case study presents latest state-of-the-art achievements.

Expert presenters

The live webcast will bring interesting case provided by Pharmatrans SANAQ® and technically discussed and presented by Philippe Tschopp, Business Development at Glatt Pharmaceutical Services in Germany and Dr. Raja Subburayalu, consultant in Manufacturing Science and Technology Transfer for Zydus Cadila Healthcare Limited, based in Ahmedabad, Gujarat, India.

Reverse Engineering

Dr Subburayalu will explore how present generic formulations focus on so-called BSC Class IV drugs in which multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption.

They will highlight how Reverse Engineering using TAP® can form an efficient key tool in the development of generic formulations. The webinar will feature a case study illustrating latest state-of-the-art achievements.

Register here for the online seminar recording

Webinar-Registrierung – Zoom

TAP Registration for Chinese Market

ingredientpharm announces that TAP Registration for Chinese Market is approved. The new Drug Master File for TAP® following ChP regulations enables to use drug formulations containing TAP® to be marketed in one of the world largest pharmaceutical markets.

TAP® is a pelletized excipient made of 100% Tartaric Acid. These functional pellets modify the local environment and increase the solubility of BSC Class IV drugs tremendously. TAP® pellets are available in different sizes from 100 µm to 1000 µm and corresponds to monographs Ph.Eur., USP/NF, JP/JPE, ChP.

See: product details

Tag Archive for: TAP